Permanent neonatal diabetes due to KCNJ11 gene mutation

Indian Journal of Pediatrics

Volumn 74, Issue 10, 2007, Pages 947-949

  Letha, S ^a   Mammen, Darly ^a   Valamparampil, Joseph J ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Glibenclamide; KCN11 gene; Kir 6.2; Permanent neonatal diabetes; Sulphonylurea

Indexed keywords

ANTIBIOTIC AGENT; GLIBENCLAMIDE; INFUSION FLUID; INSULIN;

ACUTE KIDNEY FAILURE; ARTICLE; BRAIN EDEMA; CASE REPORT; CLINICAL TRIAL; DIABETIC KETOACIDOSIS; FEMALE; GENE MUTATION; HUMAN; HYPONATREMIA; INFANT; PERITONEAL DIALYSIS; SEIZURE;

AMINO ACID SUBSTITUTION; ARGININE; BLOOD GLUCOSE; CYSTEINE; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DNA MUTATIONAL ANALYSIS; FEMALE; GLYBURIDE; HETEROZYGOTE DETECTION; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INSULIN; KIDNEY FAILURE, ACUTE; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 36949016834     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0175-y     Document Type: Article

References (10)

1. Jeha GS, Venkatesh MP, Edelen RC, Kienstra KA, Karaviti L, Fernandes CJ. Neonatal Diabetes Mellitus: patient reports and review of current knowledge and clinical practice. J Pediatr Endocrinol 2005; 18: 1095-1102.
2. Hattersley AT, Ashcroft FM. Perspectives in Diabetes: Activating Mutations in Kir6.2 and Neonatal Diabetes. New Clinical Syndromes, New Scientific Insights and New Therapy. Diabetes 2005; 54: 2503-2513.
3. Njølstad PR, Sagen JV, Bjøkhaug L, Odili S, Shehadeh N, Bakry D et al. Permanent neonatal diabetes caused by glucokinase deficiency. Inborn error of the Glucose-Insulin signaling pathway. Diabetes 2003; 52: 2854-2860.
4. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulphonylurea therapy. Diabetes 2004; 53: 2713-2718.
5. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT, Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in first 6 months of life, with phenotype determined by genotype. Diabetologia 2006; (In Press).
6. Polak M, Shield J. Neonatal Diabetes Mellitus-genetic aspects. Pediatric Endocrinol Rev 2004; 2: 193-198.
7. Sligerland AS, Bruining GJ. From gene to disease; neonatal diabetes mellitus and KCNJ11 gene. Nederlands Tijdschrist voor Geneeskunde 2005; 149: 2732-2736.
8. Gloyn AL, Cumings EA, Edghill EL, Harries LW, Scott R, Costa T et al. Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the betacell potassium adenosine triphosphate channel. J Clin Endocrinol Metabol 2004; 89: 3932-3935.
9. Koster JC, Remedi MS, Dao C, Nichols CG. ATP and Sulphonyl urea sensitivity of mutant ATP-sensitive K+ channels in Neonatal Diabetes. Diabetes 2005; 54: 2645-2654.
10. Zung A, Glaser B, Nimri R, Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metabol 2004; 89: 5504-5507.